6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: February 19, 2025
Period of Report: February 19, 2025
Accession Number: 0001213900-25-015065

View Document ↗ View on SEC.gov ↗